Caladrius Biosciences Minority Interest

Caladrius Biosciences posts a minority interest of $-250K as of June 2026. That compares with $-250K in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Caladrius Biosciences's minority interest was $-250K. The latest reading is $-250K — essentially flat versus a year earlier (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Minority Interest is one piece of Caladrius Biosciences's financial statement story. At $-250K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CLBS's minority interest usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Caladrius Biosciences's other metric pages and overview cover the third.

Judging Caladrius Biosciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in minority interest easier to interpret. Start with $-250K here, then scan peer and history charts to see if the gap is persistent.